Liability Proposals Under New EU Medtech Regs Are Misguided, Says Life Sci Legal Eagle
This article was originally published in Clinica
In the EU, the General Product Liability Directive provides the legal framework for liability for defective products in the medtech industry. But will this continue to be the case? Several clauses have been put forward by the European institutions that seek to introduce liability measures into the proposed Regulations on Medical Devices and IVDs. What are the chances of these measures actually making it into law? Amanda Maxwell spoke with Erik Vollebregt, partner at Axon Lawyers, to find out his view
You may also be interested in...
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.
With just a few months remaining until the full application of the EU Medical Device Regulation, notified body designations are still only trickling through. Ireland is the latest EU member state to have a resident MDR notified body.
In this second article of a two-part series, Eithne Lee of ISO Life Sciences global consultancy identifies some of the problems that medtech premarket innovators and SMEs are facing, with the EU MDR application date now less than four months away.